NmeCas 9 is an intrinsically high-fidelity genome editing platform 2 3 4 5

@inproceedings{Amrani2018NmeCas9I,
  title={NmeCas 9 is an intrinsically high-fidelity genome editing platform 2 3 4 5},
  author={Nadia Amrani and Xin D Gao and Pengpeng Liu and Alireza Edraki and Aamir Mir and Raed Ibraheim and 6 Ankit and Gupta and Kanae E. Sasaki and Tong Wu and Paul Daniel Donohoue and Alexander H. Settle and Alexandra M. Lied and Kyle Mcgovern and Chris K. Fuller and Peter Cameron and Thomas G Fazzio and Lihua Julie Zhu and 8 ScotA. and Wolfe and Erik J Sontheimer},
  year={2018}
}

Figures and Tables from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 92 REFERENCES

The Neisseria meningitidis CRISPR-Cas9 System Enables Specific Genome Editing in Mammalian Cells

  • Molecular therapy : the journal of the American Society of Gene Therapy
  • 2016
VIEW 10 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…